Cardiovascular Effects: Hypertension, palpitations, hypotension, postural hypotension, tachycardia, atrial fibrillation, arrhythmia,
There is a potential risk of syncope in tamsulosin treated patients. (see Precautions) Gastrointestinal Effects: Diarrhea, dyspepsia, vomiting, nausea, constipation, dry mouth, tooth disorder.
Metabolic and Nutritional Effects: Peripheral edema.
Musculoskeletal Effects: Arthralgia, myalgia, arthritis.
CNS Effects: Dizziness, dizziness (aggravated), dizzy spell, vertigo, syncope, orthostatic/circulatory collapse, somnolence, insomnia, depressed level/loss of consciousness, hypertonia, paresthesia.
Respiratory Effects: Rhinitis (including nasal congestion, nasal obstruction, stuffy nose, runny nose, sinus congestion, and hay fever), pharyngitis, increased cough, sinusitis, dyspnea, lung disorder, epistaxis.
Dermatologic Effects: Allergic type reactions such as skin rash, urticaria, pruritus, angioedema and respiratory symptoms, skin desquamation, sweating, erythema multiforme, dermatitis exfoliative, and Stevens-Johnson syndrome
Urogenital Effects: Abnormal ejaculation (including ejaculation failure, ejaculation disorder, retrograde ejaculation, and decreased ejaculation), decreased libido, priapism, reduced semen volume, urinary tract infection (UTI), dysuria, impotence.
Special Senses: Blurred vision and visual impairment. IFIS has been associated with alpha-1 blocker therapy during cataract surgery.
View ADR Reporting Link